Updated April 2026 · USPTO PatentsView
Organic Chemistry Patent Landscape
153 patents tracked across 3 companies in CPC C07.
The Organic Chemistry technology class (CPC C07) covers 153 U.S. patents tracked here, held across 3 companies. Filing activity, top patent holders, and recent grants below all come directly from USPTO records.
Patent landscape for Organic Chemistry technology (CPC class C07). Covers innovations in organic chemistry from leading companies worldwide.
Organic Chemistry at a Glance
153 patents tracked under Organic Chemistry. Smaller technology classes can be either nascent areas with growing filing activity or legacy areas where filing has slowed — the yearly trend on this page is the easiest way to tell which.
Johnson & Johnson (55 patents, grade D), Pfizer (50, grade D), and Merck (48, grade D) hold the top three positions in Organic Chemistry. The grade column reflects each company's overall Patent Strength Score across its full portfolio, not just patents in this technology class.
Patent Activity by Year
Filing activity in Organic Chemistry has accelerated, with the most recent five years averaging about 7 new patents per year — roughly 20% above the earlier window. Acceleration often correlates with a technology shift attracting fresh corporate R&D, and it tends to push expiration cliffs further out as new filings replace older ones.
Recent Patents in Organic Chemistry
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10002629 | Method for preparing scalable nano-scale derivatives | Johnson & Johnson | Dec 7, 2028 | Nov 15, 2044 | 16 | 18.6y left |
| 10002682 | Computer-implemented method for configurable digital optimization | Pfizer | Oct 10, 2028 | Jul 24, 2044 | 33 | 18.3y left |
| 10002622 | System and method for advanced data processing using edge | Johnson & Johnson | Jul 3, 2028 | Jan 16, 2044 | 9 | 17.8y left |
| 10002748 | Method for integrated cloud genetic modification | Merck | Jan 16, 2028 | Apr 21, 2044 | 39 | 18.0y left |
| 10002712 | System and method for improved data processing using quantum | Pfizer | Sep 2, 2027 | Dec 22, 2043 | 17 | 17.7y left |
| 10002666 | Pharmaceutical composition comprising multi-layer CMOS compounds | Johnson & Johnson | Aug 15, 2027 | Oct 21, 2044 | 42 | 18.5y left |
| 10002751 | Novel configurable digital compound and synthesis thereof | Merck | Aug 2, 2027 | Aug 17, 2044 | 24 | 18.4y left |
| 10002633 | Method for integrated diagnosis using CMOS | Johnson & Johnson | Jul 27, 2027 | May 22, 2044 | 8 | 18.1y left |
| 10002662 | Medical device for adaptive blockchain delivery | Johnson & Johnson | Jul 19, 2027 | Jun 8, 2044 | 18 | 18.2y left |
| 10002701 | Method of treating disease using distributed 5G therapy | Pfizer | Jul 8, 2027 | Dec 2, 2044 | 27 | 18.7y left |
| 10002632 | Therapeutic agent with multi-layer digital mechanism | Johnson & Johnson | Apr 1, 2027 | Mar 28, 2043 | 29 | 17.0y left |
| 10002624 | Apparatus for enhanced computational operations in RF environments | Johnson & Johnson | Feb 20, 2027 | Dec 3, 2043 | 40 | 17.7y left |
| 10002714 | Method for scalable diagnosis using digital | Pfizer | Dec 19, 2026 | Sep 24, 2043 | 23 | 17.5y left |
| 10002645 | Method for multi-layer machine learning inference using digital | Johnson & Johnson | Sep 23, 2026 | Jun 5, 2043 | 32 | 17.2y left |
| 10002715 | Method for high-performance blockchain genetic modification | Pfizer | Sep 18, 2026 | Sep 7, 2044 | 14 | 18.4y left |
| 10002699 | Medical device for adaptive 5G delivery | Pfizer | Sep 17, 2026 | Jan 17, 2043 | 15 | 16.8y left |
| 10002730 | System for distributed neural network processing with CMOS | Merck | Sep 15, 2026 | Mar 21, 2042 | 21 | 16.0y left |
| 10002690 | Method for preparing enhanced edge derivatives | Pfizer | Sep 11, 2026 | Aug 1, 2043 | 34 | 17.3y left |
| 10002679 | Recombinant neural protein with autonomous activity | Pfizer | Aug 10, 2026 | Aug 9, 2043 | 40 | 17.3y left |
| 10002684 | Apparatus for autonomous computational operations in lidar environments | Pfizer | Jul 18, 2026 | Jun 19, 2042 | 36 | 16.2y left |
What Expirations Mean for Organic Chemistry
As patents in Organic Chemistry expire, the underlying methods and apparatuses enter the public domain. Competitors gain freedom to operate without licensing the original claims, and downstream products incorporating the formerly protected technology can ship without a royalty stack. This is the ground-truth mechanism that drives generic-drug economics and the broader competitive dynamics in semiconductor process generations and consumer electronics platforms.
For pharmaceutical and biotech CPC classes, drug-specific exclusivities tracked in the FDA Orange Book can delay generic entry past patent expiration. For non-drug technology classes, expiration is a cleaner trigger — competitors generally gain freedom-to-operate immediately. Either way, the underlying expiration math comes from USPTO records.
How This Patent Landscape Is Built
Patents are assigned to Organic Chemistry based on their primary CPC classification (C07) as recorded by USPTO examiners. Total counts include all patents in the tracked dataset that carry this CPC prefix; recent-patent and yearly-trend tables are derived from the same record set. Each company\'s grade reflects its overall Patent Strength Score across its entire tracked portfolio, not just patents in this CPC class. Read the full methodology for the data pipeline, score weights, and known limitations.
Frequently Asked Questions
What is the Organic Chemistry CPC class?
Organic Chemistry corresponds to Cooperative Patent Classification (CPC) prefix C07, the international system used by the USPTO and EPO to organize patents by technical subject matter. Patent landscape for Organic Chemistry technology (CPC class C07). Covers innovations in organic chemistry from leading companies worldwide. CPC classes are assigned by patent examiners and update as the technology evolves, so the patent set tracked here reflects the current classification of every included patent.
Who are the top patent holders in Organic Chemistry?
Johnson & Johnson (55 patents), Pfizer (50 patents), Merck (48 patents) are the leading holders in Organic Chemistry. Patent counts at the company level are useful for spotting concentration, but they do not tell you about claim strength — for a finer signal, see each company's Patent Strength Score grade in the table below.
How many Organic Chemistry patents will expire soon?
Per-year expiration counts for this technology class can be derived from the recent patents table on this page combined with each patent's expiration date — patents typically expire 20 years from earliest non-provisional filing. For year-by-year expiration totals across all CPC classes, see the expiring-year pages on this site, which break down each year's cohort by company and technology.
What happens when patents in Organic Chemistry expire?
When a patent expires, its claims enter the public domain. For Organic Chemistry, that means competitors can implement the underlying methods or apparatus without licensing fees. The practical impact varies — in regulated areas like pharmaceuticals, FDA-granted exclusivities can extend market protection past patent expiry. In unregulated technology areas, expiration usually translates directly into freedom-to-operate for new entrants.
Where does Organic Chemistry patent data come from?
All patent data is sourced from the U.S. Patent and Trademark Office through the PatentsView and Open Data Portal APIs. CPC classifications are assigned by USPTO examiners and are part of the official patent record. Verify any individual patent through USPTO Patent Public Search (ppubs.uspto.gov) or Google Patents.
Sources: U.S. Patent and Trademark Office (PatentsView, Open Data Portal). Public-domain federal data. Cite as: "PatentCliff, Organic Chemistry landscape, April 2026. Data: USPTO."
Last updated 2026-04-10 · 153 patents tracked in Organic Chemistry.